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Encapsulation of dsDNA fragments (contour length 54 nm) by the cationic diblock 
copolymer poly(butadiene-b-N-methyl 4-vinyl pyridinium) [PBd-b-P4VPQ] has been 
studied with phase contrast, polarized light, and fluorescence microscopy, as well as 
scanning electron microscopy. Encapsulation was achieved with a single emulsion 
technique. For this purpose, an aqueous DNA solution is emulsified in an organic solvent 
(toluene) and stabilized by the amphiphilic diblock copolymer. The PBd block forms an 
interfacial brush, whereas the cationic P4VPQ block complexes with DNA. A subsequent 
change of the quality of the organic solvent results in a collapse of the PBd brush and the 
formation of a capsule. Inside the capsules, the DNA is compacted as shown by the 
appearance of birefringent textures under crossed polarizers and the increase in 
fluorescence intensity of labeled DNA. The capsules can also be dispersed in aqueous 
medium to form vesicles, provided they are stabilized with an osmotic agent (polyethylene 
glycol) in the external phase. It is shown that the DNA is released from the vesicles once 
the osmotic pressure drops below 105 N/m2 or if the ionic strength of the supporting 
medium exceeds 0.1 M. The method has also proven to be efficient to encapsulate pUC18 
plasmid in sub-micron sized vesicles and the general applicability of the method has been 
demonstrated by the preparation of the charge inverse system: cationic poly(ethylene 
imine) encapsulated by the anionic diblock poly(styrene-b-acrylic acid).  
Introduction 
Self-assembly is clearly a necessary tool to realize practical nanoscale structures. These 
nanostructures will probably involve membrane vesicles either as the nanostructures 
themselves, or as templates for more complex structures.1 Because of the large molecular 
weight, compared to lipids, most polymer membranes are hyper thick, and can thereby 
achieve far greater stability than any natural lipid membrane.2 Accordingly, although 
vesicles can also be composed of surfactants or lipids, polymeric vesicles are preferred. The 
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present contribution aims at the fundamental design, control, and structural characterization 
of a new class of such complex, self-assembled structure: cationic copolymer vesicles 
loaded with DNA. These vesicles may serve as an experimental model system for diverse 
applications such as non-viral gene delivery and packaging of DNA in, e.g., condensates, 
bacteriophages, and viruses.3,4,5,6 
Micron and nano-size polymeric vesicles and capsules have considerable potential in 
industrial, medical, and pharmaceutical applications, because of their ability to take up and 
carry a reagent through an otherwise hostile medium. The usual preparation procedure 
involves the adsorption of alternating layers of oppositely charged polyelectrolytes on a 
colloidal particle.7,8 In the next step, the colloidal core is destroyed either by UV irradiation 
or immersion in a strong acid or base. The resulting empty capsule can subsequently be 
loaded with a drug. A drawback of this method is that the molecular weight of the reagent 
is restricted by the pore size in the capsule membrane, because the reagent is usually 
introduced after the preparation of the capsule. This restriction makes it difficult to 
encapsulate rather large macromolecules such as clone vector DNA, although recently 
progress has been made by precipitation of spermidine condensed DNA onto the surface of 
template micro-particles.9 There is a clear need for high enough compaction of DNA, 
efficiency of encapsulation, and control of the structure and properties of the protective 
shell. 
Our encapsulation experiments are inspired by DNA-polycation complexes 
(polyplexes).10 DNA forms complexes with cationic polymers, which can be used for 
targeting DNA into cells.11,12 Polyplexes are formed when the DNA fuses with a cationic 
polymer and equal numbers of positive (from the DNA) and negative (from the polymer) 
small counterions are released into the bulk. This entropic gain due to counterion release is 
thought to be the driving force for the formation of the complex.13 The cationic polymer 
can differ in chemical composition and architecture of the backbone, e.g., linear, branched, 
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or diblock copolymer. As a result, a wide range of condensing agents can be synthesized 
and evaluated in order to determine the most efficient system. A common feature of the 
previously investigated systems is the micelle-like structure of the complex coarcevate.14 
The micelles contain a domain with DNA and the neutralizing polymer, possibly 
surrounded by a coronal layer composed of the neutral attachment of the copolymer. 
It is our contention that the ability of ionic diblocks to form self-assembled vesicular 
structures, together with the counterion release mechanism as a driving force for the 
complex formation, offer new opportunities for the encapsulation of charged (bio)polymers. 
Although we will demonstrate our encapsulation procedure for DNA, we argue that the 
method is more general. Our method is based on a water-in-oil emulsion as template, but, 
contrary to a similar approach reported in the literature,15 the encapsulated material is part 
of the membrane. We start with the preparation of an emulsion of aqueous droplets 
dispersed in an immiscible organic solvent and stabilized by a polyelectrolyte diblock 
copolymer. The droplets can contain any water-soluble macromolecule with opposite net 
charge to form a polyelectrolyte bilayer with the ionic block at the water/copolymer 
interface. The organic solvent should be a good solvent for the hydrophobic attachment. If 
the ionic block is sufficiently small, the good solvent quality ensures that the copolymer 
can be dissolved in the organic phase prior to mixing. The emulsion is then prepared by 
mixing the aqueous and organic phases in the right proportion. To a certain extent, the size 
of the droplets can be controlled by the emulsification procedure, e.g., by sonication or 
micro-filtration. Long time stability of the emulsion can be achieved by the appropriate 
choice of the copolymer concentration and molecular weight of the hydrophobic 
attachment. There is no restriction to the molecular weight of the material in the aqueous 
phase, because at this stage of the preparation the capsule has not been formed. 
For the formation of the capsule, the good organic solvent is replaced by a non-solvent, 
which results in a collapse of the hydrophobic chain part. The collapsed polymer layer now 
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forms a shell around the droplet, as is illustrated in Figure 1. If the non-solvent is miscible 
with water, the material in the aqueous phase gets compacted because water is extracted 
from the droplet during the encapsulation process. The volatile organic solvent can 
subsequently be evaporated to form capsules in air. To produce vesicles, the capsules can 
then be transferred into an aqueous supporting medium. It has proven to be necessary to 
immerse the capsules in polyethylene glycol (PEG) solution rather than pure water, because 
otherwise, the membrane becomes unstable and the encapsulated material is released. The 
stability of the vesicles is determined by the balance of the elastic force of the membrane 
itself and the osmotic forces exerted by the encapsulated material and the supporting 
medium, respectively. 
Apart from stabilizing the emulsion, the copolymer is also the building block of the 
polymer shell in the final stage of the preparation procedure. Accordingly, the stability and 
permeability of the membrane depend on the properties of the hydrophobic attachment 
(e.g., glass temperature, molecular weight, etc.) as well as the properties of the 
polyelectrolyte bilayer formed by the ionic block and the encapsulated material at the inner 
side of the interfacial layer. Release of the encapsulated material, which is of great 
importance in application studies, can be affected by two different, but related mechanisms. 
The first one is an imbalance in the osmotic and elastic stretching forces acting on the 
membrane, whereas the second mechanism involves a change in the permeability of the 
membrane itself. An example of the first mechanism is the release of the encapsulated 
material once the osmotic pressure exerted by the supporting medium drops below a certain 
critical value. As an example of the second mechanism, we will see below that the 
permeability of the membrane can be controlled by an increase in ionic strength through 
screening of the electrostatic interactions in the polyelectrolyte bilayer. 
The organization of this paper is as follows. First, we describe the step-wise production 
of the vesicles with the single emulsion technique. This process is followed with polarized 
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light and scanning electron microscopy, as well as fluorescence microscopy of labeled 
DNA. Then we move on to the determination of the compaction efficiency and the DNA 
density profile inside the emulsion droplets, capsules in air, and vesicles in aqueous 
medium. The stability of the vesicles against osmotic pressure and ionic strength is 
investigated by controlled release experiments using fluorescence labeled DNA. We 
demonstrate that there are no restrictions to the molecular weight of the DNA by the 
encapsulation of clone vector, pUC18 plasmid (2686 base pairs). We will also show that the 
applicability of the method is general by the preparation of the ‘charge inverse’ system: 
cationic homopolymer encapsulated by an anionic diblock copolymer.  
Experimental Section 
Chemicals and Solutions. DNA was obtained by micrococcal nuclease digestion of 
calf thymus chromatin.16 After precipitation in cold 2-propanol, the DNA pellet was dried 
under reduced pressure at room temperature. The DNA was brought to the salt free sodium 
form by dissolving it in a 50 mM NaCl, 24 mM EDTA buffer and extensive dialysis against 
water (purified by a Millipore system with conductivity less than 10-6 Ω-1cm-1). To avoid 
denaturation, care was taken that the DNA nucleotide concentration did not drop below 3 
mM nucleotides/l. The differential molecular weight distribution was monitored by size 
exclusion chromatography (SEC) with light scattering detection.17 The advantage of the 
isolation procedure is that it yields a large quantity of mononucleosomal DNA, but a typical 
batch contains approximately 25 % lower and higher molecular weight material.  
Further SEC fractionation resulted in a relatively monodisperse eluent fraction with an 
average molecular weight Mw = 104000 (158 base-pairs, contour length L = 54 nm) with 
polydispersity Mw/Mn  = 1.14. The hypochromic effect at 260 nm confirmed the integrity of 
the double helix and the ratio of the optical absorbencies A260/A280 = 1.83 indicates that the 
material is essentially free of protein.18 The material was freeze-dried and the residual water 
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content was determined by IR spectroscopy. Stock solutions were prepared by dissolving 
freeze dried Na-DNA in H2O. The DNA concentrations are 36, 18, 9, 4.5, and 2.3 g/l. The 
concentrations are determined by weight, using the water content in the freeze-dried 
material and the Na-DNA partial molar volume 165 cm3/mol. As fluorescence DNA probe, 
4',6-diamidino-2-phenylindole dichloride (DAPI) was added to the stock solutions with a 
concentration 58 µg of DAPI per gram of DNA. pUC18 plasmid was isolated from 
Escherichia coli bacteria, purified, and characterized as described in previous work.19 The 
plasmid concentration in the stock solution is 1.4 g/l. 
Poly(butadiene-b-N-methyl-4-vinyl-pyridinium iodide) [PBd-b-P4VPQI] diblock 
copolymer was purchased from Polymer Source Inc., Dorval, Canada. According to the 
manufacturer, the number-average molecular weights Mn of the PBd and P4VPQI blocks 
are 120000 and 28200 g/mol, which correspond with a degree of polymerization DP = 2220 
and 115, respectively. The molecular weight polydispersity Mw/Mn ratio of the copolymer is 
1.05. Solutions were prepared by dissolving the copolymer in toluene. The copolymer 
concentrations are determined by weight and have the values 4, 2, 1, 0.5, 0.1, and 0.01 g/l. 
Polyethyleneglycol (PEG) with molecular weight 3000 g/mol was purchased from Merck. 
Six osmotic stress solutions are prepared by dissolving the PEG in purified water. The PEG 
weight concentrations are 43, 21, 10, 5, 1, and 0.5 wt %. For the preparation of the charge 
inverse system, cationic poly(ethylene imine) (PEI) with molecular weight 35000 g/mol 
was purchased from Fluka. PEI was encapsulated with the anionic poly(styrene-b-acrylic 
acid) (PS-b-PA, Polymer Source Inc). The diblock copolymer is ‘crew cut’ with molecular 
weights 11000 and 1240 g/mol of the PS and PA blocks, respectively. The concentrations 
of the PEI in water and PS-b-PA in toluene stock solutions are 11.3 and 1.1 g/l. 
Imaging. For light microscopy, a droplet of the emulsion was deposited on a 
microscope slide and sealed with a cover slip. DNA capsules were deposited on a 
microscope slide by the procedure as described below. The capsules were either directly 
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observed in air or they were first immersed in PEG solution and sealed with a cover slip. 
Polarized light microscopy was done with a Leica DMR microscope with 10×, 63×, and 
100× (oil immersion) objectives at ambient temperature. The magnification was calibrated 
with the help of a ruler. Images were collected with a Ricoh 35 mm photo camera. Phase 
contrast and fluorescence imaging were done with an Olympus BX - 60 microscope 
equipped with a 100 W mercury lamp and a UV filter set (U-MWU/ narrow band cube; 
excitation at 330-385 nm and with an emission filter at 420 nm). The exposure time of the 
DAPI fluorescence label was controlled by a UV light shutter. Images were collected with a 
CCD camera and analyzed with the public domain software Object-Image 2.06.20 The 
radial fluorescence intensity of the emulsion droplets, capsules, or vesicles was measured 
and the background was subtracted. For scanning electron microscopy, capsules were 
deposited on a microscope slide and dried at 40 °C and 0.75 atm for one week. The 
specimens were subsequently sputter coated with gold under vacuum and imaged with a 
JEOL SEM 6400 microscope.  
Results and Discussion  
Production of the Vesicles. We will first demonstrate that our procedure can be used 
to encapsulate DNA. The first step involves the preparation of an emulsion of aqueous 
DNA droplets dispersed in toluene and stabilized with copolymer. For this purpose, two 
solutions are prepared: one solution is made of the cationic diblock poly(butadiene-b-N-
methyl-4-vinylpyridinium iodide) [PBd-b-P4VPQI] in toluene and the second one is an 
aqueous solution of 150 base-pair DNA fragments without added low molecular weight 
salt. The size of the polybutadiene attachment is sufficiently large to ensure a good 
solubility in toluene, despite the presence of the cationic block. To achieve long time 
stability of the emulsion, it proved to be necessary to dissolve 4 gram of copolymer per liter 
of toluene. For most experiments, the DNA concentration in the initial aqueous phase was 
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36 g/l. The aqueous DNA solution is then mixed with the copolymer in toluene solution in 
volume ratio 1:9, respectively, and stirred for several hours to form an emulsion. Due to the 
amphiphilic behavior of the copolymer, the hydrophobic polybutadiene attachment prevents 
the droplets from coalescence and the emulsion was observed to be stable over months. 
Figure 2 displays an optical micrograph of an emulsion of DNA/water droplets 
immersed in toluene. The size of the droplets is on the order of tens of microns, but here no 
special efforts were done for size fractionation and/or to prepare droplets of smaller size. 
The DNA concentration inside the droplets amounts 36 g/l, which is well below the critical 
concentration pertaining to the transition to the cholesteric, liquid crystalline phase (100-
220 g/l, depending on ionic strength).21 With the help of polarized light microscopy, it was 
observed that the droplets are not birefringent and, hence, the DNA is indeed not liquid-
crystalline. Fluorescence imaging with DAPI labeled DNA shows that the droplets contain 
DNA and that there is no significant amount of DNA present within the supporting toluene 
phase (see Figure 5).  
The DNA molecules form a polyelectrolyte bilayer with the cationic block at the 
copolymer/water interface and contribute to the stability of the membrane. To gauge the 
importance of the polyelectrolyte bilayer, some experiments were done in which the 
toluene was evaporated from the emulsion. If the droplets do not contain DNA, i.e. if they 
are prepared with pure water, this process results in the formation of a copolymer film. In 
the presence of DNA however, the droplets remain spherical and capsules are formed (these 
capsules are covered by a copolymer film, results not shown). It was observed, however, 
that for the lowest 2.3 g/l DNA concentration the larger droplets collapse, whereas the 
integrity of the smaller ones is preserved. These results support the view that the 
electrostatic interaction between DNA and the cationic block controls the stability and 
permeability of the membrane. Indeed, as we will see below with fluorescence microscopy, 
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screening of this interaction by the addition of low molecular weight salt results in the 
release of DNA.  
In the second step of the preparation procedure, the emulsion is transferred into ethyl 
acetate, which is a non-solvent for polybutadiene. Figure 3a displays a polarized light 
micrograph of the emulsion during solvent exchange by capillary suction of ethyl acetate 
between slide and cover slip. The micrograph shows the coexistence of non-birefringent 
droplets and birefringent capsules. After completion of the solvent exchange, all droplets 
have become birefringent and the textures are reminiscent of those observed for liquid 
crystalline DNA.22,23 Apart from the solvent quality induced collapse of the hydrophobic 
attachment, during the solvent exchange water is extracted from the capsule and the DNA 
is compacted in an orderly fashion imposed by the emulsion template. The compaction is 
facilitated by the good miscibility of water and ethyl acetate. Occasionally, we have 
observed the typical fingerprint-like textures for cholesteric DNA (as in Figure 3d), but in 
most cases the textures were quite irregular.  
As shown by polarized light, scanning electron, and fluorescence microscopy in 
Figures 3b, 4, and 5b, respectively, the integrity of the capsules is preserved after 
evaporation of the volatile ethyl acetate. In particular, there is no change in polarized light 
microscopy textures over an extended period in time. The textures show clear cholesteric 
fringes, if the dry capsules are taken up in toluene again. This observation suggests that the 
rigidity of the interfacial layer prevents uniform alignment of the liquid crystal. As we will 
see below with fluorescence microscopy, the DNA concentration inside the dry capsules is 
indeed in the range of the one pertaining to the macroscopic cholesteric phase. The 
scanning electron micrographs show that the surface of the capsules is homogeneous and 
that there is a broad distribution in capsule size with average and minimum diameter 16 and 
3 µm, respectively. Notice that the size is determined by the emulsification procedure. As 
will be shown below, sub-micron size capsules (with clone vector DNA) can be prepared if 
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the emulsion is sonicated prior to the solvent quality induced collapse of the hydrophobic 
attachment. At room temperature, polybutadiene is well above the glass temperature and 
liquid-like, which explains the tendency of the dry capsules to become stuck together once 
the solvent is evaporated. However, this does not affect the long-term stability of the 
capsules and their ability to re-disperse in aqueous medium. 
In the final stage of the preparation, vesicles are produced by transferring the capsules 
into an aqueous medium. However, the vesicles are unstable in pure water and it is 
necessary to use an osmotic agent in the external phase. Figures 3c and 3d display polarized 
light micrographs of the vesicles suspended in 43 wt % aqueous PEG solution. The 
micrographs show two types of liquid-crystalline textures in coexistence. All vesicles show 
a Maltese cross and blue and yellow interference colors generated by a full-wave 
retardation plate, which suggests that the DNA molecules are oriented perpendicular to the 
radius. Around 5 percent of the vesicles exhibit a cholesteric molecular arrangement 
(Figure 3d). In the radial direction away from the center, they show a periodicity with an 
alternation of dark and light stripes corresponding to half the cholesteric pitch. The pitch is 
2 µm, which is the same value as the one reported for the macroscopic cholesteric 
phase.22,23 The remaining vesicles do not show a periodicity in the radial direction, so there 
is no twist in orientation order with increasing distance away from the center (Figure 3c). 
The latter texture does not show, however, the characteristic fan-like shapes as reported for 
the macroscopic, high density, hexagonal phase.22,23 The absence of the fan-like shapes 
might be related to the mesoscopic dimension and the geometric frustration effect of the 
spherical interface. The fact that we observe two different textures in coexistence indicates 
that the DNA concentration is in the range of the critical boundaries pertaining to the first 
order phase transition from the cholesteric to the hexagonal phase (280-410 g/l, depending 
on ionic strength).24 This will be confirmed below with the help of fluorescence 
microscopy.  
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Density Distribution and Compaction Factors. In order to investigate the density 
distribution of the encapsulated material, we have done fluorescence microscopy with 
DAPI labeled DNA. Figure 5 displays the fluorescence micrographs of the emulsion 
droplets in toluene, dry capsules in air, and vesicles suspended in 43 wt % aqueous PEG 
solution. The radial dependencies of the corresponding, azimuthally averaged intensities are 
displayed in Figure 6. Notice that the radial coordinate has been scaled by the maximum 
radius R and the intensities have been divided by the corresponding intensities measured at 
the center of the object. As can seen in Figure 6, the scaled intensities collapse to a single 
master curve, which shows that the intensity profiles are similar for DNA confined in an 
emulsion droplet, a capsule in air, or a vesicle in aqueous medium. If the density is uniform, 
the azimuthally averaged profile of the 2D projected image of a spherical object with 
maximum radius R takes the form 
 ( ) ( )21I r R r Rα= −  (1) 
where r is the distance away from the center and α denotes a constant which is proportional 
to the DNA concentration. As can be seen in Figure 6, the radial intensities satisfy eq (1), 
which shows that the DNA distribution is indeed uniform. The deviations observed for r/R 
> 1 are related to the optical resolution of the microscope.  
For each object (i.e., droplet, capsule, or vesicle in toluene, air, and aqueous medium, 
respectively), the radius R and the fluorescence intensity at the center ( )0I r =  was 
determined from a fit of eq (1) to the radial fluorescence intensity profile. The results are 
displayed in Figure 7, for a population in radii between, say, 2 and 15 µm. For a uniformly 
filled spherical object and if the DNA concentration does not depend on the size, the 
fluorescence intensity at the center of the 2D image is linear in the radius  
 ( )0I r Rα= =  (2) 
No systematic deviation from a linear dependence of ( )0I r =  versus R in Figure 7 is 
observed. In particular, for the capsules in air and vesicles in aqueous medium the 
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fluorescence intensities show a rather strong and random scatter. This scatter is not related 
to uncertainty in the measurements, but to a variation in DNA concentration between 
capsules or vesicles of comparable size (the average concentration is size independent). As 
already shown by the occurrence of birefringent textures, the concentration increases and, 
hence, the DNA gets progressively compacted from the emulsion, through the capsules in 
air, to the vesicles in aqueous medium. The concentrations can be derived from the slopes 
α, because α is proportional to the DNA concentration and the DNA concentration inside 
the emulsion droplets is known. Results of the fit of eq (2) to the data in Figure 7 are 
collected in Table 1. From the ratios of the slopes with respect to the one pertaining to the 
emulsion (compaction factors), we obtain 240±40 and 350±50 g/l for the DNA 
concentration inside the capsules in air and vesicles in aqueous medium, respectively. 
Notice that our encapsulation procedure has resulted in a 10-fold compaction of DNA. 
It is interesting to compare the DNA concentrations with the critical boundaries in the 
bulk phase diagram of DNA with the same molecular weight. The phase diagram shows 
two first-order phase transitions. Depending on ionic strength, the isotropic-cholesteric 
phase transition occurs between 100 and 220 g/l and the transition from the cholesteric to 
the hexagonal phase takes place in the region 280-410 g/l.21,24 The DNA concentration 
inside the capsules in air, as obtained from fluorescence microscopy, is indeed in the 
cholesteric regime. However, the average DNA concentration inside the vesicles in aqueous 
medium is close to the critical boundaries pertaining to the first-order transition to the 
hexagonal phase. This explains the coexistence of vesicles exhibiting different polarized 
light microscopy textures: the structure inside around 95 percent of the vesicles is 
hexagonal and the remaining fraction is cholesteric. It also explains the observed scatter in 
fluorescence intensity; the difference in concentrations in the coexisting hexagonal and 
cholesteric bulk phases is in the range 5 to 10 percent.24  
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The fluorescence microscopy experiments support the view already obtained with 
polarized light microscopy. If the emulsion droplet is immersed in ethyl acetate, the 
hydrophobic attachment collapses and forms a membrane. During this process and after 
evaporation of the volatile organic solvent, water is extracted from the capsule until the 
osmotic pressure exerted by the DNA equilibrates the surface tension of the polymeric 
shell. The compaction, however, continues when the dry capsules are taken up in the 
aqueous PEG solution. Now, the osmotic pressure exerted by the supporting medium 
should be incorporated in the force balance. As a result, the vesicle further shrinks with a 
concomitant increase in DNA concentration and, hence, internal osmotic pressure until 
mechanical equilibrium is reached. As we will see below, a certain minimum external 
osmotic pressure is needed to balance the osmotic pressure exerted by the encapsulated 
DNA and to prevent release of the DNA into the aqueous medium. We will now further 
explore the stability of the vesicles against osmotic stress and ionic strength. 
Stability of the Vesicles. Control of the stability of the vesicles and release of the 
encapsulated material are of great importance in application studies. The stability of the 
vesicles is achieved by the balance of forces acting on the membrane. This force balance 
involves the osmotic pressure exerted by the encapsulated DNA, the surface tension of the 
membrane itself, and the pressure exerted by the osmotic agent in the supporting medium. 
At least two different, but related release mechanisms can be envisioned. The first one is an 
imbalance in the osmotic and elastic stretching forces acting on the membrane. If the 
osmotic pressure exerted by the supporting medium decreases, the vesicle is expected to 
swell with a concomitant decrease in internal pressure and increase in membrane tension 
until the force balance is reestablished. However, if the external pressure drops below a 
certain critical value, the elasticity of the membrane might not be sufficient to balance the 
internal pressure: the membrane ruptures and the DNA is released. The other mechanism 
involves a change in the properties of the membrane itself. Part of the membrane is 
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composed of a polyelectrolyte bilayer formed by the cationic block and DNA. This 
suggests that the permeability of the membrane can be controlled by ionic strength through 
screening of the electrostatic interactions in the polyelectrolyte bilayer. 
The stability of the vesicles against osmotic pressure exerted by the supporting medium 
is illustrated in Figure 8. Fluorescence (left panels) and phase contrast (right panels) 
micrographs of the same specimens clearly show the release of DNA once the PEG 
concentration drops below 5 wt %. The empty vesicles are still visible, but the shape of the 
membrane has become quite irregular. This irregularity suggests that the membrane has 
been ruptured due to the excess pressure exerted by the encapsulated DNA. Even after 
release of the DNA, the fluorescence micrographs show the incorporation of a residual 
amount of DNA in the membrane. The results are summarized in the stability diagram in 
Figure 9. Here, the minimum, average, and maximum observed radius of the vesicles is 
displayed versus the osmotic pressure of the supporting medium. The pressure has been 
derived from the experimental PEG weight fraction and the empirical relation  
 ( ) ( )0.4log 4.42 0.74 %PEG wtπ = +  (3) 
(Mw = 3000).25 It is clear that the larger vesicles are less stable; they eject their encapsulated 
material at higher external pressure (see also Figure 8). In order to confine DNA inside the 
vesicles, the minimum osmotic pressure exerted by the supporting medium is around 105 
N/m2. Notice that the latter value corresponds with the osmotic pressure of an assembly of 
long DNA molecules with concentration 150 g of DNA/l.26 
We have also investigated the stability of the vesicles against ionic strength. So far, we 
have not added any low molecular weight salt; all ions come from the DNA (sodium) and 
the cationic block (iodide). Figure 10 displays fluorescence micrographs of the vesicles in 
43 wt % aqueous PEG solution, but with various amounts of added NaCl. If the salt 
concentration does not exceed 0.1 M, the vesicles are stable and there is no change in 
confinement of the encapsulated material. For the highest employed 1 M ionic strength, the 
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DNA is released into the medium. As can be seen in the fluorescence micrograph in Figure 
10c, the shape of the empty vesicles remains quite regular and some DNA is still 
incorporated in the membrane. Contrary to the osmotic pressure induced release 
mechanism, there is no difference in permeability for DNA between vesicles of different 
size. These results suggest that the salt influences the permeability of the membrane rather 
that the membrane ruptures at certain salinity. A plausible explanation is that the membrane 
is semi-permeable for small ions, which allows Donnan salt partitioning between the 
aqueous supporting medium and the vesicle. The salt screens the electrostatic interactions 
between DNA and the cationic block in the polyelectrolyte bilayer. Due to this screening, 
the bilayer becomes less stable and eventually the membrane becomes permeable for the 
encapsulated material. Release of DNA, either by salt screening or osmotic pressure, occurs 
typically within tens of seconds to minutes.  
Clone Vector DNA and the ‘Charge Inverse’ System. To demonstrate that there are 
no restrictions to the molecular weight of the DNA, we have encapsulated pUC18 plasmid 
(2686 base pairs) in cationic PBd-b-P4VPQI vesicles by the same procedure. The polarized 
light micrograph in Figure 11a shows birefringent, liquid-crystalline capsules after the 
evaporation of the volatile organic solvent in air. For macroscopic, bulk solutions, a first 
order phase transition to a cholesteric liquid crystal has been observed with a critical 
boundary pertaining to the complete disappearance of the isotropic phase at 15 g of 
DNA/l.27 Accordingly, since the DNA concentration in the stock solution is 1.4 g/l, the 
observation of the birefringence indicates that the plasmid is compacted by at least a factor 
of 10. Sub-micron size, pUC18 capsules can be prepared by sonication of the emulsion 
prior to the solvent quality induced collapse of the copolymer layer. The size distribution of 
the capsules after evaporation of the volatile solvent was investigated with scanning 
electron microscopy. With a sonication power of 25 W applied for 5 minutes, a lognormal 
distribution was obtained with average capsule diameter 0.7±0.2 µm. The minimum 
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observed diameter was 0.3 µm. As in the case of DNA fragments, the pUC18 capsules can 
be transferred into aqueous medium to produce vesicles with the help of an osmotic agent. 
With gel electrophoresis, we have checked that the integrity of the plasmid is preserved 
after subsequent release induced by either an increase in ionic strength or a decrease in 
external osmotic pressure. The position of the electrophoresis band and the absence of band 
smear show that the released plasmid is free and not complexed with cationic copolymer.  
Finally, we show that our method is not unique for DNA, but that it can also be used to 
encapsulate other macromolecules. As an example, we have prepared the charge inverse 
system: capsules of cationic poly(ethylene imine) (PEI) encapsulated by the anionic diblock 
poly(styrene-b-acrylic acid) (PS-b-PA) copolymer. For this purpose, stock solutions of PEI 
in water and ‘crew cut’ PS-b-PA were mixed in volume ratio 1:9 to form an emulsion. 
Subsequently, the hydrophobic PS attachment was collapsed and dry capsules were made 
according to the procedure as described above for the encapsulation of DNA. A typical 
light micrograph of these capsules is displayed in Figure 11b. Vesicles can subsequently be 
produced by transferring them into water, provided they are stabilized with PEG. 
Conclusions 
We have demonstrated that we can achieve efficient encapsulation and at least a 10-
fold compaction of short fragment DNA with a cationic diblock copolymer and a single 
emulsion technique. In principle, there are no restrictions to the molecular weight of the 
DNA and there is no need for precipitation onto template particles, since the material is 
inserted in the emulsion droplets before the membrane has been formed. Another advantage 
is that the size of the vesicles can be controlled by the emulsification procedure. To 
illustrate these features, we also have prepared sub-micron size vesicles loaded with clone 
vector, pUC18 plasmid. Around 5 percent of the vesicles with short fragment DNA exhibit 
a cholesteric texture under crossed polarizers. The remaining fraction does not show a 
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periodicity in light intensity in the radial direction, which suggests that the molecules are 
hexagonally ordered. They do not show, however, the characteristic fan-like shapes. This 
might be related to the mesoscopic dimension and the geometric frustration of the spherical 
copolymer interface. The DNA inside the vesicles is tightly packed. As derived from the 
concentration, the interaxial spacing between the molecules is around 3.3 nm, which is 
similar to that in DNA condensates and phage heads.4,5 
The mechanism for the confinement of the DNA inside the vesicles is the elasticity of 
the membrane formed by the complex of the collapsed copolymer and DNA. We have 
achieved long-time stability of the vesicles by using an osmotic agent in the supporting 
medium. Apart from stability, controlled release is also of great importance for practical 
applications. We have demonstrated that the DNA is released once the osmotic pressure of 
the supporting medium drops below a certain critical value. The larger vesicles are less 
stable against osmotic pressure, which indicates release by rupture of the membrane. 
Another characteristic property is the sensitivity to ionic strength. The stability and 
permeability of the membrane depend on the electrostatic interactions between the ionic 
block of the copolymer and DNA. At very high salinity (around 1 M), the electrostatic 
interactions in the polyelectrolyte bilayer are effectively screened and the membrane 
becomes permeable for the encapsulated material. It was checked with electrophoresis that 
the released plasmid is truly free and not complexed with copolymer. This indicates the 
absence of co-adsorbed cationic copolymer inside the vesicles. In this respect, our method 
differs from the classical preparation of non-viral gene delivery systems, where all DNA is 
complexed with cationic polymer. 
We have demonstrated that the encapsulation method can also be used to encapsulate 
other charged (bio)polymers. As an illustrative example, we have prepared the inverse 
system: capsules of cationic poly(ethylene imine) encapsulated by the anionic diblock 
poly(styrene-b-acrylic acid) copolymer. Since the copolymer is also the building block of 
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the membrane, its chemical composition and molecular weight control the stability and 
functionality of the vesicle. In particular, the stability of the self-assembled structure in 
various environments needs to be optimized to suit the particular application. A promising 
option is chemical cross-linking (polymerizing) of the collapsed polymer layer. Other 
promising features are the possibilities to control biodegradability and tissue-specific 
adaptation by the specific choice of copolymer. 
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Table 1. Slopes α resulting from the fit of eq (2) to the fluorescence intensities in Figure 7 
for emulsion droplets in toluene, capsules in air, and vesicles in aqueous PEG solution. 
Notice that the margins refer to a variation in DNA concentration between capsules or 
vesicles of comparable size, rather than uncertainty in the measurements. 
 
 α (au) CDNA (g/l) 
Droplets 0.08±0.01 36 
Capsules 0.5±0.1 240±40 
Vesicles 0.8±0.1 350±50 
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Legends to the figures  
 
Figure 1 Schematic representation of an emulsion droplet in a good (top) and poor 
(bottom) solvent for the hydrophobic chain part. The change of the solvent quality results in 
a collapse of the interfacial polymer layer. 
 
Figure 2 Light microscopy image of a DNA emulsion stabilized with PBd-b-P4VPQ 
diblock copolymer and suspended in toluene. The DNA concentration inside the droplets 
amounts 36 g/l and the initial copolymer concentration in toluene is 4 g/l. 
 
Figure 3 Polarized light microscopy of the encapsulation process: (a) emulsion phase 
in a mixture of toluene and ethyl acetate; (b) capsules after evaporation of the volatile 
organic solvent in air; (c) vesicles immersed in aqueous PEG solution (CPEG = 43 wt %); 
(d) as in (c) but for cholesteric vesicles. Notice that the micrograph in (a) shows the 
coexistence of emulsion droplets and birefringent DNA capsules. 
 
Figure 4 Scanning electron microscopy images of DNA capsules at two different 
magnifications indicated by the bars. 
 
Figure 5 Fluorescence micrographs showing labeling of DNA by DAPI; (a) emulsion 
droplets in toluene; (b) capsules in air; (c) vesicles immersed in aqueous PEG solution 
(CPEG  = 43 wt %). 
 
Figure 6 Radial distribution of the fluorescence intensity of DAPI labeled DNA 
inside an emulsion droplet in toluene (squares), a capsule in air (circles), and a vesicle 
immersed in aqueous PEG solution (43 wt %, triangles). The intensities are normalized to 
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the intensity at the center of the 2D image of the object, whereas the radial coordinate is 
scaled by the radius R. The solid curve represents a fit of a uniform profile eq (1) with R = 
1.5, 2.6, and 4.8 µm in toluene, air, and PEG solution, respectively. 
 
Figure 7 Fluorescence intensity at the center of the 2D image of droplets in toluene 
(triangles), capsules in air (circles), and vesicles in aqueous PEG solution (0.43 wt %, 
squares). The solid lines represent linear fits of eq (2) with slopes collected in Table 1. 
Notice that the scattering of the data is largely due to the variation in DNA concentration 
inside capsules or vesicles of comparable size. 
 
Figure 8 Fluorescence (left panels) and phase contrast (right panels) micrographs 
showing the stabilization of the vesicles by osmotic stress exerted by PEG in aqueous 
solution. From top to bottom the PEG concentration decreases according to CPEG = 43 (a), 
21 (b), 10 (c), and 1 wt % (d). Notice that DNA is released for CPEG = 1 wt %. 
 
Figure 9 Minimum (circles), average (triangles), and maximum (squares) radius of 
the vesicles versus the osmotic pressure exerted by PEG in aqueous solution. 
 
Figure 10 Fluorescence micrographs showing the destabilizing of the capsules by an 
increase of the ionic strength of the supporting medium: (a) no added salt, (b) 0.1 M NaCl, 
and (c) 1 M NaCl. The PEG concentration amounts CPEG = 43 wt %. Notice that for salt 
concentrations exceeding 0.1 M the DNA is released. 
 
Figure 11 Light micrographs of (a) pUC18 plasmid encapsulated by cationic PBd-b-
P4VPQ (between crossed polarizers) and (b) PEI encapsulated by anionic PS-b-PA.  
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